Advertisement
Canada markets close in 4 hours 3 minutes

  • S&P/TSX

    22,737.34
    -250.94 (-1.09%)
     

  • S&P 500

    5,416.41
    -87.00 (-1.58%)
     

  • DOW

    40,390.31
    -365.44 (-0.90%)
     

  • CAD/USD

    0.7372
    -0.0034 (-0.46%)
     

  • CRUDE OIL

    67.71
    -1.44 (-2.08%)
     

  • Bitcoin CAD

    73,418.66
    -2,677.37 (-3.52%)
     

  • XRP CAD

    0.71
    -0.03 (-4.08%)
     

  • GOLD FUTURES

    2,537.90
    -5.20 (-0.20%)
     

  • RUSSELL 2000

    2,094.83
    -37.22 (-1.75%)
     

  • 10-Yr Bond

    3.6820
    -0.0490 (-1.31%)
     

  • NASDAQ

    16,713.44
    -414.22 (-2.42%)
     

  • VOLATILITY

    23.16
    +3.26 (+16.39%)
     

  • FTSE

    8,181.47
    -60.24 (-0.73%)
     

  • NIKKEI 225

    36,391.47
    -265.62 (-0.72%)
     

  • CAD/EUR

    0.6644
    -0.0019 (-0.29%)
     
MARKETS LIVE BLOG:

STOCKS PULL BACK AFTER U.S. JOBS REPORT SHOWS MORE COOLING

Print shifts expectations for Fed to enact a more sizeable cut at its meeting in under two weeks

Qiagen: Q1 Earnings Snapshot

Associated Press Finance
·1 min read

PL VENLO, Netherlands (AP) — PL VENLO, Netherlands (AP) — Qiagen NV (QGEN) on Monday reported first-quarter profit of $80.7 million.

The Pl Venlo, Netherlands-based company said it had net income of 36 cents per share. Earnings, adjusted for non-recurring costs, were 46 cents per share.

The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 44 cents per share.

The diagnostic products maker posted revenue of $458.8 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $455.5 million.

Qiagen expects full-year earnings to be $2.10 per share, with revenue expected to be $2 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QGEN at https://www.zacks.com/ap/QGEN